New data suggests that retatrutide, a novel medication, might represent a significant step in weight management. This therapy combines the properties of a GLP-1 agonist and a GIP agonist , seemingly offering a enhanced impact than current therapies . Study research have shown positive outcomes, including substantial reductions in size and gains in